Effect of ramipril on the incidence of diabetes.

By J. Bosch, S. Yusuf, H. Gerstein, Janice Pogue, P. Sheridan, G. Dagenais, R. Diaz, Á. Avezum, F. Lanas, J. Probstfield and 3 more. New England Journal of Medicine, 2006

649 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/2e0958a18a2b75ec52f3cc704ece42b1a3dfaee5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. M. Quon
2. K. Koh
3. R. Eckel
4. M. Montagnani

Citations in the corpus

• The metabolic syndrome. (2008, result): “Metformin, which has a primary mechanism of action of reducing hepatic glucose production, has been shown to reduce the progression of diabetes from IGT by approximately 31% in the DPP, of which 53% had the MetS (591).”
• Cardiovascular actions of insulin. (2007, background): “lenge glucose levels and increased the likelihood of regression to normoglycemia in subjects with impaired glucose tolerance and impaired plasma glucose levels (425).”